Optometrist · El Paso, TX
NPI
1275938557
Since 2014
Specialty
Optometrist
Code 152W00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
8894 Gateway North Boulevard
El Paso, TX, 79904
Phone (915) 751-7760
Groups this clinician bills Medicare through
Medicare paid, 2024
$26K
469 services
Medicare patients, 2024
227
Average age 72
Drug cost, 2024
$882K
2,762 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cory A Grifka was code 92014 (ophthalmological e&m), 139 times for 138 patients. In total Cory A Grifka billed 469 services in 14 codes, and Medicare paid $26K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-08-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92014 Ophthalmological E&M | Office | 139 | 138 | $68.93 | $9,581 |
| 99213 Office E&M - Established | Office | 63 | 50 | $64.84 | $4,085 |
| 92133 Computerized Ophthalmic Imaging | Office | 49 | 49 | $18.43 | $903 |
| 92004 Ophthalmological E&M | Office | 43 | 43 | $76.13 | $3,274 |
| 92134 Computerized Ophthalmic Imaging | Office | 41 | 41 | $26.04 | $1,068 |
| 92012 Ophthalmological E&M | Office | 35 | 31 | $50.75 | $1,776 |
| 92083 Vision, Hearing, and Speech Services | Office | 27 | 27 | $40.49 | $1,093 |
| 99214 Office E&M - Established | Office | 21 | 16 | $80.42 | $1,689 |
| 92250 Angiography | Office | 19 | 19 | $22.01 | $418 |
| 68761 Eye | Office | 14 | 11 | $151.05 | $2,115 |
By year: 2022 $40K for 676 services; 2023 $33K for 541 services; 2024 $26K for 469 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cory A Grifka prescribed most often to Medicare patients was Latanoprost, with 770 prescriptions and refills. In total Cory A Grifka wrote 2,762 Medicare prescriptions that cost $882K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Latanoprost Generic | 770 | 1,837 | 299 | $10K |
| Prednisolone Acetate Generic | 271 | 348 | 211 | $9,899 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 230 | 599 | 87 | $3,941 |
| Vyzulta Latanoprostene Bunod | 211 | 464 | 79 | $133K |
| Xdemvy Lotilaner | 184 | 269 | 149 | $364K |
| Timolol Maleate Generic | 100 | 253 | 47 | $591 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 100 | 218 | 36 | $14K |
| Restasis Cyclosporine | 97 | 209 | 42 | $125K |
| Ketorolac Tromethamine Generic | 83 | 121 | 67 | $3,436 |
| Brimonidine Tartrate Generic | 72 | 178 | 27 | $1,680 |
| Xiidra Lifitegrast | 72 | 155 | 35 | $108K |
| Moxifloxacin Moxifloxacin Hcl | 68 | 68 | 59 | $2,425 |
| Fluorometholone Generic | 65 | 70 | 61 | $3,827 |
| Lumigan Bimatoprost | 54 | 124 | 19 | $33K |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 49 | 49 | 42 | $609 |
Brand drugs: 1,550 claims; generic drugs: 1,212 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Cory A Grifka were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.